InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Karydas Daphne. Insider active across 1 company, notably Mineralys Therapeutics, Inc.. In total, 4 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €65k. Activity tracked since 13 November 2025. The latest transaction was disclosed on 31 March 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Karydas Daphne is a declarant linked to Mineralys Therapeutics, Inc. (XNAS), where the listed role is Director. She has 4 filings in total, and among the sampled recent filings, sales total 64799 EUR between 2025-11-13 and 2026-04-02, with the transaction nature listed as option exercise.